Last reviewed · How we verify
other class IC antiarrhythmic drug — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
other class IC antiarrhythmic drug (other class IC antiarrhythmic drug) — Korea University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| other class IC antiarrhythmic drug TARGET | other class IC antiarrhythmic drug | Korea University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- other class IC antiarrhythmic drug CI watch — RSS
- other class IC antiarrhythmic drug CI watch — Atom
- other class IC antiarrhythmic drug CI watch — JSON
- other class IC antiarrhythmic drug alone — RSS
Cite this brief
Drug Landscape (2026). other class IC antiarrhythmic drug — Competitive Intelligence Brief. https://druglandscape.com/ci/other-class-ic-antiarrhythmic-drug. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab